Français
ItalianoBond AstraZeneca 4% ( US04636NAQ60 ) in USD
| Issuer | AstraZeneca | ||||||
| Market price |  97.054 % ▼ |
||||||
| Country |  United Kingdom
|
||||||
| ISIN code |
 US04636NAQ60 ( in USD )
|
||||||
| Interest rate | 4% per year ( payment 2 times a year) | ||||||
| Maturity | 03/01/2031 | ||||||
| Minimal amount | / | ||||||
| Total amount | / | ||||||
| Cusip | 04636NAQ6 | ||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | A1 ( Upper medium grade - Investment-grade ) | ||||||
| Next Coupon | 03/02/2027 ( In 129 days ) | ||||||
| Detailed description |
AstraZeneca is a British-Swedish multinational pharmaceutical and biopharmaceutical company that discovers, develops, manufactures, and markets prescription drugs globally. The Bond issued by AstraZeneca ( United Kingdom ) , in USD, with the ISIN code US04636NAQ60, pays a coupon of 4% per year. The coupons are paid 2 times per year and the Bond maturity is 03/01/2031 The Bond issued by AstraZeneca ( United Kingdom ) , in USD, with the ISIN code US04636NAQ60, was rated A1 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AstraZeneca ( United Kingdom ) , in USD, with the ISIN code US04636NAQ60, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||